Stanley P, Sundaram S, Sallustio S
Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461.
Glycobiology. 1991 Jun;1(3):307-14. doi: 10.1093/glycob/1.3.307.
A novel lectin-resistance phenotype was displayed by a LEC10 Chinese hamster ovary (CHO) cell mutant that was selected for resistance to the erythroagglutinin, E-PHA. Biochemical and genetic analyses revealed that the phenotype results from the expression of two glycosylation mutations, LEC10 and lec8. The LEC10 mutation causes the appearance of N-acetylglucosaminyltransferase III (GlcNAc-TIII) activity and the production of N-linked carbohydrates with a bisecting GlcNAc residue. The lec8 mutation inhibits translocation of UDP-Gal into the Golgi lumen and thereby dramatically reduces galactosylation of all glycoconjugates. This reduction in galactose addition does not, however, cause Lec8 mutants to be very resistant to the galactose-binding lectin, ricin. By contrast, the double mutant LEC10.Lec8 behaved like a LEC10 mutant and was highly resistant to ricin. Based on structural studies of cellular glycopeptides as well as glycopeptides of the G glycoprotein of vesicular stomatitis virus grown in mutant cells, it appears that the ricin resistance of LEC10.Lec8 cells is due to the presence of a small number of Gal residues on branched, N-linked carbohydrates that also carry the bisecting GlcNAc residue. Labelling of N-linked cellular carbohydrates with [3H]galactose was found to occur at a low level for a wide spectrum of cellular glycoproteins in independent Lec8 mutants. Studies of the LEC10.Lec8 mutant have, therefore, led to the identification of a subset of structures that are acceptors for Gal when intra-Golgi UDP-Gal levels are limiting. This mutant also illustrates the potential for regulating cell surface recognition by carbohydrate-binding proteins by altering the expression of a single glycosyltransferase such as GlcNAc-TIII.
一株LEC10中国仓鼠卵巢(CHO)细胞突变体表现出一种新的凝集素抗性表型,该突变体是通过对红细胞凝集素E-PHA的抗性筛选出来的。生化和遗传学分析表明,该表型是由两个糖基化突变LEC10和lec8的表达所致。LEC10突变导致N-乙酰葡糖胺转移酶III(GlcNAc-TIII)活性出现,并产生带有平分型GlcNAc残基的N-连接碳水化合物。lec8突变抑制UDP-Gal转运到高尔基体腔中,从而显著降低所有糖缀合物的半乳糖基化。然而,半乳糖添加的这种减少并不会使Lec8突变体对半乳糖结合凝集素蓖麻毒素具有很强的抗性。相比之下,双突变体LEC10.Lec8的表现类似于LEC10突变体,对蓖麻毒素具有高度抗性。基于对细胞糖肽以及在突变细胞中生长的水泡性口炎病毒G糖蛋白糖肽的结构研究,看来LEC10.Lec8细胞对蓖麻毒素的抗性是由于在分支的、N-连接碳水化合物上存在少量的Gal残基,这些碳水化合物也带有平分型GlcNAc残基。在用[3H]半乳糖标记N-连接的细胞碳水化合物时,发现独立的Lec8突变体中广泛的细胞糖蛋白的标记水平较低。因此,对LEC10.Lec8突变体的研究导致鉴定出当高尔基体腔内UDP-Gal水平有限时作为Gal受体的结构子集。该突变体还说明了通过改变单一糖基转移酶如GlcNAc-TIII的表达来调节碳水化合物结合蛋白对细胞表面识别的可能性。